BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.
CAS:1286279-29-5
分子式:C25H40N8O2
分子量:484.64
纯度:98%
存储:Store at -20°C
Background:
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.
参考文献:
[1]. Norman P. et al. A dual CCR2/CCR5 chemokine antagonist, BMS-813160 Evaluation of WO2011046916. Expert Opin Ther Pat. 2011 Dec;21(12):1919-24.